The fourth edition of the World Health Organization (WHO) classification of tumours of the
central nervous system, published in 2007, lists several new entities, including angiocentric …

In sclerosing epithelioid fibrosarcoma (SEF), a rare variant of low-grade fibrosarcoma,
treatment results and therapeutic options are poorly characterized. We systematically …

Low-grade fibromyxoid sarcomas (LGFMS) bear either the t (7, 16)(q32-34; p11) or t (11,
16)(p11; p11) translocations, resulting in FUS-CREB3L2 or FUS-CREB3L1 fusions …

Sclerosing epithelioid fibrosarcoma (SEF) is an uncommon tumor of deep soft tissues,
originally described in 1995 by Meis–Kindblom et al. In the current study, the authors …

Sclerosing epithelioid fibrosarcoma is a rare tumour characterised histologically by a
predominant population of epithelioid cells arranged in strands and nests, embedded in a …

Sclerosing epithelioid fibrosarcoma (SEF) is a rare and aggressive soft-tissue sarcoma
thought to originate in fibroblasts of the tissues comprising tendons, ligaments, and muscles …

Sclerosing epithelioid fibrosarcoma (SEF) has distinctive morphology and occurs mainly in
deep soft tissue of adult extremities. Approximately 59 cases of SEF have been reported …

Soft Tissue Sarcomas (STS) is a heterogeneous and complex group of mesenchymal tumors
with an annual incidence of 50–60 new cases per million people and year, which means …

Sclerosing epithelioid fibrosarcoma (SEF) is a rare soft tissue sarcoma mostly occurring in
extraosseous sites. SEF represents a clinically challenging entity especially because no …

Sclerosing epithelioid fibrosarcoma (SEF) is a rare and distinct variant of fibrosarcoma,
composed of epithelioid tumor cells arranged in strands, nests, cords, or sheets embedded …